74226-22-5
74226-22-5
Chemical Structure
Dazoxiben hydrochloride
Synonym(s): UK 37248
- CAS No.: 74226-22-5
- Formula:C12H13ClN2O3
- Molecular Weight:268.70
IUPAC Name: 4-(2-(1H-imidazol-1-yl)ethoxy)benzoic acid hydrochloride
InChIKey: PVKDFUXBDJPRGU-UHFFFAOYSA-N
SMILES: OC(C1=CC=C(OCCN2C=CN=C2)C=C1)=O.[H]Cl
Biological Activity: Dazoxiben hydrochloride is a potent and orally active thromboxane (TX) synthase inhibitor[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Dazoxiben hydrochloride | 99.90% | Dazoxiben hydrochloride is a potent and orally active thromboxane (TX) synthase inhibitor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dazoxiben hydrochloride (Standard) | ≥98% | Dazoxiben (hydrochloride) (Standard) is the analytical standard of Dazoxiben (hydrochloride). This product is intended for research and analytical applications. Dazoxiben hydrochloride is a potent and orally active thromboxane (TX) synthase inhibitor. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Dazoxiben | Dazoxiben is a potent and orally active thromboxane synthetase inhibitor. Dazoxiben has the potential for the research of Raynaud's syndrome. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Camonagrel | Camonagrel is a compound that has inhibitory effects on Prostaglandin E2. Camonagrel is a potent thromboxane synthase inhibitor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Heme Oxygenase-1-IN-1 hydrochloride | 99.03% | Heme Oxygenase-1-IN-1 (Compound 2) hydrochloride is a heme oxygenase 1 (HO-1) inhibitor with an IC50 of 0.25 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
LG 82-4-00 | LG 82-4-00 is a thromboxane (TX) synthase inhibitor with an IC50 value of 1.1 μM. LG 82-4-00 can inhibit collagen-induced TXB2 formation and platelet aggregation in plasma. LG 82-4-00 can be used in studies related to thrombotic diseases. |
|||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
mGluR7-IN-1 | mGluR7-IN-1 (compound 2Z) is a mGluR3 inhibitor. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Raloxifene impurity 7 | Raloxifene impurity 7 is an impurity of Raloxifene. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-((4-Carboxybenzyl)oxy)benzoic acid | 4-((4-Carboxybenzyl)oxy)benzoic acid (4-[(4-Carboxyphenoxy)methyl]-benzoic acid) is a metal-organic framework (MOF). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
1,3-Bis(p-carboxy-phenoxy)propane | 1,3-Bis(p-carboxy-phenoxy)propane (1,3-Bis(4-carboxyphenoxy)propane) is a metal-organic framework (MOF). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
NW-1689 | 99.54% | NW-1689 is a process-related impurity of safinamide mesilate (SAFM). SAFM can be used for the study of Parkinson's disease (PD). It is a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium channels and N-type calcium channels. These effects of SAFM help reduce the breakdown of dopamine and inhibit the release of glutamate. NW-1689 has a similar chemical structure to SAFM and has some similar pharmacological effects as SAFM, and can be used in Parkinson's disease research. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4,4'-(Methylenebis(oxy))dibenzoic acid | 4,4'-(Methylenebis(oxy))dibenzoic acid is a metal-organic framework (MOF). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
